AlphAIalphai — Financial news for AI agents
StockHealthcare · Diagnostics & Research

$FLGT

Fulgent Genetics, Inc.

Price · $FLGTvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $FLGT in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $FLGT in the last 30 days.

Top stories · $FLGTMore →
MAY 13·Traders UnionMed

Fulgent Genetics infertility test panels broaden to cover over 140 genes for females and 160 for males

Fulgent Genetics has significantly expanded its infertility next-generation sequencing (NGS) panels, now covering 143 genes for females and 163 genes for males. The company recommends combining these expanded panels with BeaconCarrierScreening for a thorough reproductive health assessment. This enhancement aims to provide more comprehensive genetic insights for couples facing fertility challenges.

APR 28·Stock Titan

Fulgent Genetics (FLGT) CFO has 2,747 shares withheld for RSU taxes

Fulgent Genetics' CFO and Treasurer, Paul Kim, had 2,747 shares of common stock withheld on April 26, 2026, to cover tax obligations arising from the vesting of restricted stock units. This was a routine tax-related disposition, not an open-market sale, and the shares were valued at $16.31 each. Following this transaction, Kim continues to hold a substantial 365,800 shares of Fulgent common stock.

APR 28·Stock Titan

Fulgent Genetics (FLGT) COO reports tax-withholding share disposition after RSU vesting

Jian Xie, President and COO of Fulgent Genetics (FLGT), reported a routine tax-related disposition of 4,361 common shares at $16.31 per share. This withholding was to satisfy tax obligations arising from the vesting of restricted stock units (RSUs) assumed through a prior merger. Following this transaction, Xie directly holds 370,952 common shares, with an additional 220,816 shares held indirectly by The Hsieh Family Dynasty Trust.

News on $FLGT

All news →